Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xyotax and Alimta in advanced NSCLC
NCT00487669Phase 2Completed
- Sponsor
- Dartmouth Health
- Start
- Oct 2006
- Primary completion
- Nov 2009
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of paclitaxel poliglumex in non-small cell lung cancer (NSCLC), sponsored by Dartmouth Health. Started Oct 2006; status: completed.
02
Drugs
paclitaxel poliglumex
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00487669.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00487669.